1,3-dimethyl-norbornan-2-one | 80538-37-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 1,3-dimethyl-norbornan-2-one
• 英文别名: 1.3-Dimethyl-bicyclo-[1.2.2]-heptanon-(2)；1,3-Dimethyl-norbornan-2-on；Fenchosantenon；Dimethylnorbornanon；1,3-dimethylbicyclo[2.2.1]heptan-2-one
• CAS: 80538-37-0
• 化学式: C₉H₁₄O
• 分子量: 138.21
• InChiKey: XSBBRSJXZUUBDR-UHFFFAOYSA-N

物化性质

• 沸点：
  196.3±8.0 °C(Predicted)
• 密度：
  1.012±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  1-methyl-norbornan-2-one 、 碘甲烷 在 乙醚 、 sodium amide 作用下， 生成 1,3-dimethyl-norbornan-2-one
  参考文献：
  名称：

  Ruzicka, Chemische Berichte, 1917, vol. 50, p. 1367

  摘要：

  DOI：

文献信息

• Process for making an aldehyde
  申请人：Wyeth

  公开号：US20040082785A1

  公开（公告）日：2004-04-29

  A process for making an aromatic aldehyde in which a sulfoxide is reacted with a dihalogenated aromatic compound in the absence of an effective amount of an activating reagent. The aldehyde may then be used to make other compounds, such as a compound that acts as a cPLA inhibitor.

  一种制备芳香醛的过程，其中亚砜与双卤代芳香化合物在缺乏有效量活化试剂的情况下发生反应。然后可以使用该醛制备其他化合物，例如作为cPLA抑制剂的化合物。
• CYSTEINE DERIVATIVES
  申请人：Ajinomoto Co., Inc.

  公开号：EP1120407A1

  公开（公告）日：2001-08-01

  Objects of the present invention are to provide an oxidative stress inhibitor which is capable of suppressing the expression of a cytotoxic protein and the activation of a gene transcriptional regulatory factor taking part such expression of a cytotoxic protein and exhibits good feeling upon use and safety; to provide a method for preventing, retarding, alleviating or treating a skin change due to aging or an undesirable aesthetic skin change, both caused or promoted by an oxidative stress; and to provide a cosmetic composition or dermatologic preparation for external use comprising the oxidative stress inhibitor as an effective ingredient, and for those purposes are employed an oxidative stress inhibiting agent which comprises, as an effective ingredient, at least one selected from cysteine or cystine derivatives and the salts thereof.

  本发明的目的是提供一种氧化应激抑制剂，它能够抑制细胞毒性蛋白的表达和参与细胞毒性蛋白表达的基因转录调控因子的活化，并在使用时具有良好的感觉和安全性；提供一种方法，用于预防、延缓、减轻或治疗由氧化应激引起或促进的皮肤老化变化或皮肤美容方面的不良变化；以及提供一种外用化妆品组合物或皮肤病制剂，其中包含作为有效成分的氧化应激抑制剂，并为此目的采用一种氧化应激抑制剂，其中包含作为有效成分的至少一种选自半胱氨酸或胱氨酸衍生物及其盐类的氧化应激抑制剂。
• Use of guaiol for treating the skin
  申请人：Baschong Werner

  公开号：US20050058610A1

  公开（公告）日：2005-03-17

  The use is described of compositions comprising (a) (−)-guaiol, (b) further skin-lightening active substance(s) and, optionally, (c) one or more UV-A and/or UV-B absorbers as melanogenesis inhibitors and for skin-lightening.

  所述组合物的用途包括：(a) (-)- 愈创木酚；(b) 其他皮肤美白活性物质；(c) 一种或多种 UV-A 和/或 UV-B 吸收剂，作为黑色素生成抑制剂和皮肤美白剂。
• Micro-Particulate Organic Uv Absorber Composition
  申请人：Deshayes Cyrille

  公开号：US20080019929A1

  公开（公告）日：2008-01-24

  Disclosed is a topically applicable water-in-oil (w/o) or water-in-silicone (w/Si) formulation comprising: (a) at least one aqueous phase; (b) at least one fatty phase; (c) an effective UV-photoprotecting composition comprising (c 1 ) 20% to 99% of at least one insoluble micronized organic UV-screening active with a mean particle size ranging from 0.01 μm to 2 μm; and (c 2 ) 0.5% to 80% of at least one primary C 6 -C 28 fatty alcohol. The combination of a micronized organic UV absorber and a specific fatty alcohol allows a maximum of miscibility of micronized organic particles within the continuous oil phase of w/o emulsion wherein the micronized particles are stabilized in the oil phase of the composition. Simultaneously the crystal growth of micronized organic UV absorbers within W/O emulsions is limited or even eliminated.
• Hair care formulations comprising UV absorbers and certain silicone derivatives
  申请人：Tsotsoros Rhonda F.

  公开号：US20100021407A1

  公开（公告）日：2010-01-28

  This invention relates to hair conditioning formulations comprising at least one aminofunctional polyorganosiloxane. Furthermore, the invention relates to the use of these formulations for the treatment of keratin-containing fibers, preferably human hair.